Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Adienne S A has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, ALSOMAIRY, SARAH ABDOALATIF, who is the busiest examiner for the portfolio. The prosecution is occurring within 1 distinct art unit, reflecting a very specific focus for the company's current patenting activity. This concentration suggests that the company is presently prioritizing a single technological advancement within the broader pharmaceutical field.
The busiest_examiner_pending count for ALSOMAIRY, SARAH ABDOALATIF is 1, which represents the entirety of the company's pending office actions. This indicates that the company's current prosecution strategy in the Biotechnology & Pharmaceuticals area is concentrated on a single application. All current examiner communications are centralized under this one individual and art unit. Practitioners should focus on the specific requirements of this one examiner, as their feedback will determine the outcome for the entire active portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALSOMAIRY, SARAH ABDOALATIF | 1 | 57.4% | +30.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18507904 | METHODS OF TREATING GRAFT VERSUS HOST DISEASE | ALSOMAIRY, SARAH ABDOALATIF | — |
| Art Unit | Apps |
|---|---|
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18507904 | METHODS OF TREATING GRAFT VERSUS HOST DISEASE | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103 | Final Rejection | — | Pending | Nov 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAdienne S A has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sarah Abdoalatif Alsomairy has the most, with 1 of Adienne S A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
